Click here to see a list of our past events.
Cornell Research & Innovation offers the virtual Innovation & Entrepreneurship Workshop Series to faculty, staff, post-docs, graduate and undergraduate students, and alumni at Cornell University to explore the potential of launching a business grounded in research. Questions? Contact crea@cornell.edu.
Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!
Do you have disruptive science but struggle to bring it to life in the entrepreneurial world? Bayer's passion is to enable and support standout healthcare innovation.
Take your innovation to new heights and join Bayer's Expert Mondays 2024, a series of knowledge exchange sessions to supercharge your startup’s growth.
Each one-hour Bayer's Expert Monday includes a live Q&A with respective Bayer Experts. You can stay for a Meet & Greet with Bayer Scouts and Scientific Finders. Please reserve 30 additional minutes in your schedule for the Meet & Greet after the Bayer Expert session.
These sessions are not intended for service providers, consultants, IT providers, etc. They are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities later in their journey. Session recordings are NOT distributed afterward. Live attendance is necessary to get the most out of the expert sessions and network with the Bayer Pharma team.
The Sep 30 event features Dr. Anja Moews and Dr. Torsten Hertramp, Senior Directors BD&L, Due Diligence Center of Excellence. Reserve your spot here.
This event is part of an SBIR/STTR workshop series. It will feature an overview of NIH- and NCI-wide aspects of the federal SBIR/STTR programs and is open to WCM and non-WCM guests from various disciplines of science and medicine. Following the presentation, select inventors/companies will have the opportunity to meet one-on-one with Dr. Gregory Evans from the NCI.
Please indicate your interest in a 1:1 meeting in the registration form. You will not be scheduled for a 1:1 meeting if you do not select the option to request a 1:1 in the RSVP.
All 1:1 meetings will be in-person and take place on WCM campus (location and time will be sent to each individual confirmed for a 1:1 meeting in a calendar invite a few days prior to the event).
Led by the NSF I-Corps Hub: Interior Northeast (IN I-Corps), these free NSF I-Corps Regional Courses are designed for university-based STEM researchers and early-stage founders interested in evaluating the market potential of their technology and learning valuable entrepreneurial skills
In this month-long, virtual course (October 14 - November 14), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit.
Applications will be reviewed on a rolling basis. Apply now. Application closes on Wednesday, September 18. Questions? Contact icorps@cornell.edu or visit www.in-icorps.org/regional-courses.
Are you an academic researcher, PI, professor, or graduate student with an interest in entrepreneurship or commercializing your technology? Join Osage University Partners on September 12 at 1pm ET, to learn about an incredible 2-year program.
- Activate is a two-year fellowship that provides early-stage hard-tech science entrepreneurs $100K in research funding, yearly stipends of $100K, intensive entrepreneurial training, mentorship, networking, and other benefits. Activate Fellows have raised over $2B in follow-on funding from leading public and private sources.
- Activate’s Cohort 2025 applications are open on September 4, and Activate will accept applications through October 23, 2024 at 5pm PT / 8pm ET.
Karrigan Turner and Rick Kempinski of Activate will join OUP's Nabil Ullah to talk about the program and answer questions live.
Register now.
Cornell innovators are welcome to explore research translation and entrepreneurship at this free workshop! Focused on the roles that startup founders with scientific backgrounds can take in their new ventures, this workshop is the perfect fit for researchers interested in pursuing commercialization of their innovative technologies.
Find out how to maximize the impact of your innovations and play the most effective part in your company at this free event. Stephanie Wisner, a former chemical biology researcher now serving as the Chief Business Officer at Centivax, will moderate a panel with other scientific startup founders.
Register here. Questions? Contact crea@cornell.edu.
Ready to secure non-dilutive funding to take your startup to the next level?
Join Kirk Macolini, President of InteliSpark, LLC, for this virtual workshop providing insights into the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process and how to find other non-dilutive funding sources. During the workshop, Macolini will discuss and answer questions regarding:
- Writing and submitting a successful SBIR/STTR proposal
- Identifying strategies for making your SBIR/STTR proposal more competitive
- Applying to the SBIR/STTR Assistance Program, which can help eligible companies, based in New York state, hire a qualified grant writing consultant to help them develop a proposal
Upon registering, participants will receive access to the SBIR/STTR video series, a set of short videos containing valuable background information, which they are encouraged to view prior to the workshop. The pre-workshop video series covers:
- An overview of the SBIR/STTR programs
- Program eligibility requirements
- Differences between SBIR and STTR agencies
- Using SBIR/STTR to enhance your company's value
The event is free and open to the public. Register to reserve your spot.
The U.S. Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER) Small Business and Industry Assistance (SBIA) in conjunction with the National Institutes of Health (NIH) will host a webinar entitled Regulatory Do’s and Don’ts: Tips from FDA.
The webinar aims to educate early-stage companies (small businesses) new to the regulatory landscape at the FDA. This activity is intended to provide an overview on resources and programs that FDA has developed across the Center for Biologics Evaluation and Research (CBER), CDER, and the Center for Devices and Radiological Health (CDRH) that can help academic life-science accelerators and early-stage, oncology-related companies develop new anticancer-therapeutics, devices, and diagnostics. Additionally, there will be a Q&A at the end of each session for the audience to ask questions.
Topics will include:
- Regulatory resources and early engagement programs available at FDA centers (CBER, CDER, and CDRH)
- Chemistry, Manufacturing, and Controls (CMC), non-clinical, and clinical guidance documents for early product development
- Early-stage
- Small molecule drug and biologic anticancer-drug development
- Cell and gene therapy anticancer-drug development
- Anticancer-device and diagnostic development
Additional details:
Attendance is virtual, and continuing education credits are available. The webinar is free, but registration is required. The intended audience is academic spin-off and early-stage companies (small businesses) developing therapies, devices, diagnostics, and digital health technologies as well as researchers and health care professionals developing new anti-cancer drugs.
Led by the NSF I-Corps Hub: Interior Northeast (IN I-Corps), these free NSF I-Corps Regional Courses are designed for university-based STEM researchers and early-stage founders interested in evaluating the market potential of their technology and learning valuable entrepreneurial skills
In this month-long, virtual course (September 30 - October 30), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit.
Applications will be reviewed on a rolling basis. Apply now. Application closes on Wednesday, September 4. Questions? Contact icorps@cornell.edu or visit www.in-icorps.org/regional-courses.
Meet Dr. Annie De Groot, co-founder and CSO of EpiVax, Inc. Dr. De Groot's work has impacted the fields of vaccine development and immunoinformatics, including advancing the creation of many effective and safe immunotherapies. Join us to learn about:
- Her journey from medicine to startup founder
- EpiVax’s innovative immunogenicity tools
- Current applications of AI and Human Intelligence (HI) to immunogenicity risk assessments and vaccine design
Dr. De Groot will be interviewed by Loren A. Busby, director of the BioVenture eLab. Register now.
